In today’s ACT Brief, we examine why outdated views of Asia Pacific trial sites persist, how community access gaps reflect ...
Risk-based quality management (RBQM) aims to detect the right signals early enough to prevent an issue from occurring. To ...
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how FDA ...
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how regulatory reform and inspection data contradict the view that APAC sites are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results